Welcome to Francis Academic Press

Academic Journal of Humanities & Social Sciences, 2021, 4(11); doi: 10.25236/AJHSS.2021.041117.

Discussion on Human Gene Editing Technology from the Perspective of Ethics and Law


Hechun Wang 

Corresponding Author:
Hechun Wang

University of Washington, Washington 98105, USA


In recent years, there are more and more achievements in gene editing technology, and more and more private individuals begin to study gene editing technology. Gene editing technology is a hot topic both in medical circles and in legal circles. Different from traditional genetic engineering technology, gene editing technology has powerful functions and accuracy, which can effectively cure various human genetic diseases and prolong human life expectancy. However, while enjoying the great benefits brought by gene editing technology to mankind, we must also realize that a series of moral and ethical problems caused by gene editing technology have also promoted the improvement of China's legislative model in the field of gene editing. From the perspective of ethics and law, this paper studies the relevant laws and regulations of gene editing technology from many aspects, and effectively points out the application scope of the technology and the consensus that the current society should reach on the application of the technology.


Human gene editing technology; Genetic engineering; Ethics; Law

Cite This Paper

Hechun Wang. Discussion on Human Gene Editing Technology from the Perspective of Ethics and Law. Academic Journal of Humanities & Social Sciences (2021) Vol. 4, Issue 11: 84-88. https://doi.org/10.25236/AJHSS.2021.041117.


[1] Hsu, Patrick D., et al. “Development and Applications of CRISPR-Cas9 for Genome Engineering.” Cell, vol. 157, no. 6, 2014, pp. 1262–1278.

[2] Zetsche, Bernd, et al. “Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System.” Cell, vol. 163, no. 3, 2015, pp. 759–771.

[3] Cho, Seung Woo, et al. “Targeted Genome Engineering in Human Cells with the Cas9 RNA-Guided Endonuclease.” Nature Biotechnology, vol. 31, no. 3, 2013, pp. 230–232.

[4] Komor, Alexis C., et al. “Programmable Editing of a Target Base in Genomic DNA without Double-Stranded DNA Cleavage.” Nature, vol. 533, no. 7603, 2016, pp. 420–424.

[5] Cyranoski, D., CRISPR gene-editing tested in a person for the first time. Nature, 2016. 539(7630): p. 479.

[6] Gaudelli, Nicole M., et al. “Programmable Base Editing of A•T to G•C in Genomic DNA without DNA Cleavage.” Nature, vol. 551, no. 7681, 2017, pp. 464–471.

[7] Kleinstiver, Benjamin P., et al. “High-Fidelity CRISPR–Cas9 Nucleases with No Detectable Genome-Wide off-Target Effects.” Nature, vol. 529, no. 7587, 2016, pp. 490–495.

[8] Cyranoski, David, and Heidi Ledford. “Genome-Edited Baby Claim Provokes International Outcry.” Nature, vol. 563, no. 7733, 2018, pp. 607–608.